Ryan M. Carnahan, PharmD: The Relationship of an Anticholinergic Rating Scale With Serum Anticholinergic Activity in Elderly Nursing Home Residents

Name: Ryan M. Carnahan, PharmD: The Relationship of an Anticholinergic Rating Scale With Serum Anticholinergic Activity in Elderly Nursing Home Residents
SKU: 3043
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 36 No. 4 Articles Tags: anticholinergic, brian-c-lund, bruce-g-pollock, delirium, elderly, kennith-r-culp, paul-j-perry, pharmd, radioreceptor-assay, ryan-m-carnahan, serum-anticholinergic-activity

Description

Ryan M. Carnahan, PharmD: The Relationship of an Anticholinergic Rating Scale With Serum Anticholinergic Activity in Elderly Nursing Home Residents

Description

Ryan M. Carnahan, PharmD

DRUG DISPOSITION & PHARMACOKINETICS

The Relationship of an Anticholinergic Rating Scale With Serum Anticholinergic Activity in Elderly Nursing Home Residents

Ryan M. Carnahan, PharmD, Brian C. Lund, PharmD, MS, BCCP, Paul J. Perry, PhD, Kennith R. Culp, PhD, and Bruce G. Pollock, MD, PhD

C. Lindsay DeVane, PharmD: Risperidone in the Management of Psychiatric and Neurodegenerative Disease in the Elderly: An Update

Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia

John L. Beyer, MD: Patterns of Pharmacotherapy and Treatment Response in Elderly Adults with Bipolar Disorder

Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia

Ryan M. Carnahan, PharmD: The Relationship of an Anticholinergic Rating Scale With Serum Anticholinergic Activity in Elderly Nursing Home Residents

Description

Ryan M. Carnahan, PharmD

DRUG DISPOSITION & PHARMACOKINETICS

The Relationship of an Anticholinergic Rating Scale With Serum Anticholinergic Activity in Elderly Nursing Home Residents

Ryan M. Carnahan, PharmD, Brian C. Lund, PharmD, MS, BCCP, Paul J. Perry, PhD, Kennith R. Culp, PhD, and Bruce G. Pollock, MD, PhD

Related products

C. Lindsay DeVane, PharmD: Risperidone in the Management of Psychiatric and Neurodegenerative Disease in the Elderly: An Update

Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia

John L. Beyer, MD: Patterns of Pharmacotherapy and Treatment Response in Elderly Adults with Bipolar Disorder

Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia